Standards for Robust Evidence from Digital Health in Oncology

Due to the lack of industry-wide evidence frameworks  for digital health solutions in oncology, regulators’ and payers' requirements are usually the same as drugs. However, drugs and oncology digital health solutions are very different in nature, and it is hard to fit those digital solutions into the traditional evidence standards. On top of that, digital health companies have limited resources (money, time and people), which can get in the way of building more robust evidence.